DexCom, Inc. (0A4M.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 06:00AM BST. Market open.
| Previous close | 131.96 |
| Open | 134.30 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 134.30 - 134.30 |
| 52-week range | 74.71 - 138.89 |
| Volume | |
| Avg. volume | 2,732 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | 2.75 |
| EPS (TTM) | 0.49 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksDexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
ZacksAhead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
- Zacks
Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom
Vertiv, Align Technology and DexCom are part of the Zacks Investment Ideas article.
© 2024 Yahoo. All rights reserved.